Explore it now
27th Annual ESGO 2026 Congress
Discover it Now!
ENGOT coordinates and promotes gynaecological cancer clinical trials in Europe
Explore ENGOT
Explore ESGO’s Membership Benefits
Read More
Europe's Leading Gynaecological Oncology Congress
Visit ESGO Congress Site
ESGO has officially welcomed its new President during the ESGO 2026 Congress in Copenhagen.
Read press release
Congratulations to the six newly elected ESGO Council members: Benedetta Guani, Giovanni Aletti, Karin Stålberg, Michael Seckl, Ranjit Manchanda & Vladyslav Sukhin, who will join the Council in leading ESGO until 2030.
View Council
Held alongside the 2026 European Congress on Gynaecological Oncology, the ESGO Legacy event convened leading experts, policymakers, patient advocates and industry representatives in Copenhagen to advance sustainable improvements in women’s cancer care.
ESGO hosted a High-Level Policy Event at the European Parliament on 28 January 2026, focusing on women’s health and presenting its proposal for an EU-wide network of Centres of Excellence. Check out our advocacy page for the recording and to read ESGO's position paper.
Read more
ESGO's Prevention Committee has published a paper in the prestigious Journal of the American Medical Association (JAMA). The paper is titled 'Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma'. Congratulations to all authors involved.
Read publication
Read the press release for ESGO 2026: Europe's largest gynaecological oncology congress.
Join over 3,000 colleagues worldwide in the leading network of gynaecological oncology professionals, and access resources and opportunities designed to support you at every stage of your career. Renew or register for 2026 today and start enjoying your membership immediately.
Find out more
This review explores the environmental impact of gynaecological oncology, focusing on the significant carbon footprint of healthcare services such as surgery, imaging, and anaesthesia.
Read the article
22.06.2026 - 23.06.2026 London, UK Level: Basic
Learn more
10.09.2026 - 25.09.2026 Valencia Spain Level: Advanced
14.12.2026 - 15.12.2026 Milan, Italy Level: Advanced
ESGO's official journal
Read the latest content
→ Explore IJGC
The ESGO TransLink project is a new initiative to establish a network of research groups in gynaecological oncology, uniting efforts across Europe and worldwide to accelerate research and collaboration across all gynaecological cancers.
Explore Olivia, a digital patient pathway that seeks to address the many challenges women with ovarian cancer face. Read More
View Press Release and Video
For more information view the Ovarian Cancer Commitment
Cecilia represents the cervical cancer patient pathway, helping to communicate key moments in diagnosis, treatment, and follow-up from a patient perspective.
ENGAGe’s Diagnosis Delivery Cards provide an innovative way for doctors to deliver gynaecological cancer diagnoses with clarity and empathy. Tear-off sheets give patients a clear reference for better understanding and emotional support.
Meet Emilia – an ESGO & ENGAGe patient character who is helping shine a light on the patient pathway of endometrial cancer.
Watch Emilia's story
Read brochure
European Network of Gynaecological Oncological Trial groups (ENGOT)
ENGOT is a research network of ESGO, which promotes cooperative studies and coordinates clinical trials in gynaecological oncology within Europe.
→ View trials
European Network of Young Gynaecological Oncologists (ENYGO)
ESGO established ENYGO to shape the future of female cancer research and treatment in Europe.
→ Read more
ESGO established ENGAGe to raise awareness to the need for further research and to improve patients access to quality treatment and care at both national and European levels.
→ View activities